Articles
Time | 2021-12-23 | PDF>
Role of duodenal inflammation in functional dyspepsia Functional dyspepsia (FD) refers to recurrent upper gastrointestinal (GI) symptoms with no structural explanation. As one of the most common functional GI disorders, no cure for FD has been established and thus significantly affects quality ofTime | 2021-06-10 | PDF>
Progesterone attenuates visceral pain through the mucosal mast cell-derived 5-hydroxytryptamine and vagal 5-hydroxytryptamine 3 receptor signaling in rats Qing Liu*, Xiu-Juan Yan*, Er-Man Wang, Chen-Chen Feng, Sheng-Liang Chen Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai Institute of Digestive Disease, Shanghai 200001, ChinaTime | 2020-12-11 | PDF>
Application of neurotransmitter regulators in refractory functional gastrointestinal disorders The application of neurotransmitter regulators (mainly antidepressants) is one of the theoretical and practical breakthroughs to improve the therapeutic efficacy of refractory functional gastrointestinal disorders (rFGIDs). The targets of neurotranTime | 2020-06-20 | PDF>
The role of circadian rhythms in digestive psychosomatic disorders Digestive psychosomatic disorders (DPSD) are prevalent in the clinics of physical and mental diseases. Their diagnosis and treatment are facing enormous challenges. The pathophysiological mechanisms underlying various symptoms of DPSD are still not fTime | 2019-12-25 | PDF>
Brain-gut interactions and management of gastrointestinal motility disorders Gastrointestinal dysmotility is involved in the pathogenesis of almost all of the disorders of gastrointestinal tract. This article addresses the relationships between dysmotility of various parts of the gastrointestinal tract with the holistic mTime | 2019-06-21 | PDF>
Efficacy of St. John's wort compound preparation (Shugan Jieyu capsule) combined with mosapride for the treatment of functional dyspepsia: a multicenter real-world clinical study To observe the clinical efficacy of concomitant use of Shugan Jieyu capsule (a St. John's wort compound preparation) and mosapride citrate dispersible tablets in the treatment of functional dyspepsia (FD).